Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07288775Not ApplicableActive Not Recruiting

Relationship Between Sleep-Wake Quality and Nocturnal Medical Orders

Role: lead

NCT05228912Completed

Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.

Role: lead

NCT04810949Not ApplicableTerminated

Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml

Role: lead

NCT03775057Not ApplicableUnknown

Use of the MyDose Coach Digital Tool for Self-titration of Insulin in Patients With Type 2 Diabetes

Role: collaborator

All 4 trials loaded